Immunogenicity of ribonucleic acid-protein fraction of Mycobacterium tuberculosis encapsulated in liposomes

References

1. Alving C. R. 1987; Liposomes as carriers for vaccines. In Ostro M. J. (ed) Liposomes from biophysics to therapeutics Marcel Dekker, Inc; New York: pp 195–218
   [Google Scholar]
2. Bennacerraf B., Sebestyen M. M., Schlossman S. 1959; A quantitative study of the kinetics of blood clearance of 32P-labelled Escherichia coli and staphylococci by the reticuloendothelial system. Journal of Experimental Medicine 110:27–48
   [Google Scholar]
3. Bondevik H., Mannick J. A. 1968; RNA mediated transfer of lymphocytes vs target cell activity. Proceedings of the Society for Experimental Biology and Medicine 129:264–268
   [Google Scholar]
4. Burton K. 1956; A study of conditions and mechanism of the diphenylamine reaction for the colorimetric estimation of deoxyribonucleic acid. Biochemical Journal 62:315–323
   [Google Scholar]
5. Collins F. M., Mackaness G. B. 1970; The relationship of delayed hypersensitivity to acquired antituberculous immunity I. Tuberculin sensitivity and resistance to reinfection in BCG-vaccinated mice. Cellular Immunology 1:253–265
   [Google Scholar]
6. Crowle A. J. 1958; Lung density as a measure of tuberculosis involvement in mice. American Review of Tuberculosis and Pulmonary Diseases 77:681–693
   [Google Scholar]
7. Falk R. E., Zabriskie J. B. 1971 In Bloom B. R., Glade P. F. (eds) In vitro methods in cell-mediated immunity Academic Press; New York: pp 301–306
   [Google Scholar]
8. Freund J. 1956; The mode of action of immunological adjuvants. Advanced Tuberculosis Research 1:130–148
   [Google Scholar]
9. Gregoriadis G., Allison A. C. 1974; Entrapment of proteins in liposomes prevents allergic reactions in pre-immunised mice. FEBS Letters 45:71–74
   [Google Scholar]
10. Gregoriadis G., Neerunjun D. E. 1974; Control of the rate of hepatic uptake and catabolism of liposome-entrapped proteins injected into rats: possible therapeutic applications. European Journal of Biochemistry 47:179–185
    [Google Scholar]
11. Hotchkiss R. D. 1957; Methods for characterization of nucleic acid. In Colowick S. P., Kaplan N. O. (eds) Methods in enzymology vol 3 Academic Press, Inc; New York: pp 708–715
    [Google Scholar]
12. Jerne N. K., Henry C., Nordin A. A., Fuji H., Koros A. M. C., Lefkovits I. 1974; Plaque forming cells. Methodology and theory. Transplantation Reviews 18:130–191
    [Google Scholar]
13. Karber. 1931; Beitrag zur Kallektiven Behandlung pharmakologischer Reihenversuche. Archives of Experimental Pathology and Pharmacology 162:480
    [Google Scholar]
14. Khuller G. K., Dogra A., Malik U., Asotra S. 1984; Macromolecular biosynthesis in Mycobacterium smegmatis ATCC 607 in the presence of antibodies to mannophosphoinositides. Journal of General Microbiology 130:1795–1798
    [Google Scholar]
15. Leon L. L. 1980; Immunization of mice with Trypanosoma cruzi polyribosomes. Infection and Immunity 27:38–43
    [Google Scholar]
16. Likhite V., Sehon A. 1972; Cell-mediated tumor allograft immunity in vitro transfer with RNA. Science 175:204–205
    [Google Scholar]
17. Lopez-Berestein G. 1987; Liposomes as carriers of antimicrobial agents. Antimicrobial Agents and Chemotherapy 31:675–678
    [Google Scholar]
18. Lowry O. H., Rosebrough N. J., Farr A. L., Randall R. J. 1951; Protein measurement with the folin phenol reagent. Journal of Biological Chemistry 193:265–275
    [Google Scholar]
19. Marmur J. 1961; A procedure for the isolation of deoxyribonucleic acid from micro-organisms. Journal of Molecular Biology 3:208–218
    [Google Scholar]
20. Morrison N. E., Collins F. M. 1976; Restoration of T-cell responsiveness by thymosin: development of antituberculous resistance in BCG infected animals. Infection and Immunity 13:554–563
    [Google Scholar]
21. Mehta P. K., Khuller G. K. 1988; Protective immunity to experimental tuberculosis by mannophosphoinositides of mycobacteria. Medical Microbiology and Immunology 177:265–284
    [Google Scholar]
22. Orozco L. C., Quintana F. O., Beltran R. M., de Moreno I., Wasserman M., Rodriquez G. 1986; The use of rifampicin and isoniazid entrapped in liposomes for the treatment of murine tuberculosis. Tubercle 67:91–97
    [Google Scholar]
23. Portelance V., Boulanger R. P., Robillard P. 1974; Mice tuberculosis quantified by the lung density technique. Canadian Journal of Microbiology; 201247–1255
    [Google Scholar]
24. Purnima Nain C. K., Vinayak V. K. 1987; Vaccination against experimental hepatic amoebic infection–an evaluation of phosphatidylcholine liposomes as immunopotentiator. Journal of Parasitology 73:859–860
    [Google Scholar]
25. Schulkind M. L., Ellis E. F., Smith R. T. 1967; Effect of antibody upon clearance 125I-labelled pneumococci by the spleen and liver. Pediatrics Research 1:178–184
    [Google Scholar]
26. Sripati C. E., Warner J. R. 1978; Isolation, characterization and translation of mRNA from yeast. Methods in Cell Biology 20:61–80
    [Google Scholar]
27. Sundararaj T., Agarwal S. C. 1977; Cell-mediated immunity to Nocardia asteroides induced by its ribonucleic acid protein fraction. Infection and Immunity 18:253–256
    [Google Scholar]
28. Van Rooijen N., Van Nieuwmegen R. 1980; Liposomes in immunology: Multilamellar phosphatidylcholine liposomes as a simple, biodegradable and harmless adjuvant without any immunogenic activity of its own. Immunological Communications 9:243–256
    [Google Scholar]
29. Vinayak V. K., Purnima Saxena A. 1987; Immunoprotective behaviour of plasma-membrane-associated antigens of axenic Entamoeba histolytica. Journal of Medical Microbiology 1A:297–302
    [Google Scholar]
30. Vinayak V. K., Sharma R. 1986; Phosphatidylcholine liposomes as effective adjuvant for vaccination of mice against Plasmodium yoelii. Indian Journal of Medical Research 84:32–38
    [Google Scholar]
31. Vladimirsky M. A., Ladigina G. A. 1983; Antibacterial activity of liposome-entrapped streptomycin in mice infected with Mycobacterium tuberculosis. Biomedicine and Pharmacotherapy 36:375–377
    [Google Scholar]
32. Youmans A. S., Youmans G. P. 1966a; Preparation of highly immunogenic ribosomal fractions of Mycobacterium tuberculosis by use of sodium dodecyl sulfate. Journal of Bacteriology 91:2139–2145
    [Google Scholar]
33. Youmans A. S., Youmans G. P. 1966b; Effect of trypsin and ribonuclease on the immunogenic activity of ribosomes and ribonucleic acid isolated from Mycobacterium tuberculosis. Journal of Bacteriology 91:2146–2154
    [Google Scholar]
34. Youmans A. S., Youmans G. P. 1967; Preparation and effect of different adjuvants on the immunogenic activity of mycobacterial ribosomal fraction. Journal of Bacteriology 94:836–843
    [Google Scholar]
35. Youmans A. S., Youmans G. P. 1971; Failure of synthetic polynucleotides to affect the immunogenicity of mycobacterial ribonucleic acid and ribosomal protein preparations. Infection and Immunity 3:149–153
    [Google Scholar]
36. Youmans A. S., Youmans G. P. 1972; Effect of polybasic amines on the immunogenicity of mycobacterial ribonucleic acid. Infection and Immunity 6:798–804
    [Google Scholar]
37. Youmans G. P. 1979 In Youmans G. P. (ed) Tuberculosis. W. B. Saunders Co; Philadelphia: pp 277–283